May 3, 2017 NIAID Funding News
Read this full issue online at https://www.niaid.nih.gov/
Feature Articles
NIAID's Review and Committee Volunteers Have Our Thanks
On behalf of NIAID and our research community, we offer thanks to the fiscal year 2016 Members of NIAID Peer Review Groups and Advisory Committees.
Opportunities and Resources
Explore Dysregulation of Immune Cell Regulatory Pathways by Mtb
Apply to a new funding opportunity announcement if you can conduct innovative preclinical research to identify and characterize Mycobacterium tuberculosis (Mtb)-mediated changes in key immune cell regulatory pathways in the context of HIV infection and evaluate strategies to reverse them.
Clinical Researchers: An Opportunity To Be a Lasker Scholar
This might appeal to early-career clinical researchers: a chance to develop into an independent scientist while receiving NIH funding for up to 10 years.
In The News
News Briefs
- Respond to RFI on FY 2019 Trans-NIH Plan for HIV-Related Research
- Form Change for Successor-in-Interest (Type 6 Parent) Application Package
- CARB-X Program Announces Initial Portfolio
- Application Due Dates Falling on Weekends Carry Over to Next Business Day
Advice Corner
Get Ready, Get Set, Apply Early
Once your application is ready, submitting it well in advance of the deadline gives you time to address problems that might cause your application to be automatically withdrawn and not reviewed.
Reader Questions
- Who has the rights to publications and data developed under a grant?
- Must I receive prior approval before submitting a program project (P01) application?
New Funding Opportunities
- PAR-17-263, Innovation for HIV Vaccine Discovery (R01)
- RFA-HL-17-023, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)
- RFA-HL-17-024, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42)
- RFA-HL-17-025, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)
- RFA-HL-17-026, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1)
- RFA-HL-17-027, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)
- RFA-HL-17-028, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)
- RFA-HL-17-029, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01)
- RFA-HL-17-030, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24)
- RFA-HL-17-031, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2)
- RFA-HL-17-032, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50)
- RFA-HL-17-033, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)
- RFA-HL-17-034, Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
.png)
No hay comentarios:
Publicar un comentario